|
Re: Currently Scheduled Still?
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 01:36PM
|
|
Re: AGM
|
3
|
Resverlogix Corp.
|
Jul 09, 2023 11:15AM
|
|
Re: Times frames FDA/BP/RVX deal
|
3
|
Resverlogix Corp.
|
Jun 11, 2020 01:11PM
|
|
if your thinking 3 months out for a rv or zen deal, think again...
|
3
|
Resverlogix Corp.
|
Mar 14, 2021 05:50PM
|
|
Re: you won’t see anyone buying this
|
3
|
Zenith Epigenetics
|
Dec 12, 2023 08:37AM
|
|
Re: Where is the bottom?
|
3
|
Resverlogix Corp.
|
Dec 12, 2019 07:05PM
|
|
Re: DM conflict of interest
|
3
|
Resverlogix Corp.
|
Nov 16, 2023 09:29AM
|
|
Stevero..?
|
3
|
Resverlogix Corp.
|
Nov 12, 2020 11:43AM
|
|
Re: Little confused, any insight would be great
|
3
|
Resverlogix Corp.
|
Mar 07, 2024 04:15PM
|
|
Re: Name Confusion
|
3
|
Zenith Epigenetics
|
Aug 12, 2020 02:22PM
|
|
wondering about this FDA letter & what it might say?
|
3
|
Resverlogix Corp.
|
Jun 17, 2020 12:30PM
|
|
Re: Name Confusion
|
3
|
Zenith Epigenetics
|
Jul 29, 2020 10:58AM
|
|
Re: Long Covid
|
3
|
Resverlogix Corp.
|
Jan 22, 2024 06:19PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Mar 31, 2020 07:02PM
|
|
Re: what if Don
|
3
|
Resverlogix Corp.
|
Oct 12, 2021 01:28PM
|
|
Re: Name Confusion
|
3
|
Zenith Epigenetics
|
Aug 12, 2020 03:04PM
|
|
Re: Zenith Epigenetics Announces Collaboration with NCI in Developing ZEN-3694 for Multiple Oncology Indications
|
3
|
Zenith Epigenetics
|
Oct 05, 2020 05:10PM
|
|
$4.35 can
|
3
|
Resverlogix Corp.
|
Apr 23, 2019 10:47AM
|
|
Re: Shorts
|
3
|
Resverlogix Corp.
|
Feb 10, 2024 10:46AM
|
|
Re: Sorry, did I miss something?
|
3
|
Resverlogix Corp.
|
Dec 09, 2020 05:41PM
|
